SOPHiA GENETICS SA (SOPH)
NASDAQ: SOPH · Real-Time Price · USD
4.370
-0.370 (-7.81%)
At close: Nov 7, 2025, 4:00 PM EST
4.400
+0.030 (0.69%)
After-hours: Nov 7, 2025, 4:10 PM EST
SOPHiA GENETICS Market Cap
SOPHiA GENETICS has a market cap or net worth of $296.49 million as of November 7, 2025. Its market cap has increased by 36.11% in one year.
Market Cap
296.49M
Enterprise Value
278.25M
1-Year Change
36.11%
Ranking
Category
Stock Price
$4.37
Market Cap Chart
Since the IPO on July 23, 2021, SOPHiA GENETICS's market cap has decreased from $1.12B to $296.49M, a decrease of -73.54%. That is a compound annual growth rate of -26.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 7, 2025 | 296.49M | 45.36% |
| Dec 31, 2024 | 203.97M | -33.51% |
| Dec 29, 2023 | 306.77M | 131.92% |
| Dec 30, 2022 | 132.27M | -85.31% |
| Dec 31, 2021 | 900.39M | -19.63% |
| Jul 23, 2021 | 1.12B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 839.37B |
| Johnson & Johnson | 450.47B |
| AbbVie | 387.13B |
| UnitedHealth Group | 291.28B |
| AstraZeneca | 260.82B |
| Novartis AG | 242.27B |
| Abbott Laboratories | 217.27B |
| Merck & Co. | 212.91B |